A Structurally Stabilized Lipopolymer Nanoplatform Targeting Pan‐Tissue Antigen‐Presenting Cells Enables Durable in situ mRNA Cancer ImmunotherapyL L Zeng, Xuesi Chen, Lingyu Wei et al.|Advanced Materials|2026Cited by 0